10
STATEMENTS 2008 on Head and Neck Cancer Stephane TEMAM, M.D. PhD. Department of Head and Neck Surgery Mucosal Melanoma

STATEMENTS 2008 on Head and Neck Cancer Stephane TEMAM, M.D. PhD. Department of Head and Neck Surgery Mucosal Melanoma

Embed Size (px)

Citation preview

Page 1: STATEMENTS 2008 on Head and Neck Cancer Stephane TEMAM, M.D. PhD. Department of Head and Neck Surgery Mucosal Melanoma

STATEMENTS 2008on Head and Neck Cancer

Stephane TEMAM, M.D. PhD.

Department of Head and Neck Surgery

Mucosal Melanoma

Page 2: STATEMENTS 2008 on Head and Neck Cancer Stephane TEMAM, M.D. PhD. Department of Head and Neck Surgery Mucosal Melanoma

EPIDEMIOLOGY

• A rare disease <1% all melanoma• >50% of MM are in the head and

neck• Incidence remained stable• ♂ > ♀

• 7th decade

Page 3: STATEMENTS 2008 on Head and Neck Cancer Stephane TEMAM, M.D. PhD. Department of Head and Neck Surgery Mucosal Melanoma

DIAGNOSIS

• Pigmented mucosal lesions

• Primary vs. metastasis– Pathological characteristics (IHC)– Precursor lesions

Page 4: STATEMENTS 2008 on Head and Neck Cancer Stephane TEMAM, M.D. PhD. Department of Head and Neck Surgery Mucosal Melanoma

STAGING and WORKUP

• AJCC 2002 TNM classification is not accurate because almost all patients are T4b (>4 mm in thickness)

• A total body skin examination• CT-Scan / MRI of the head and neck

• DM– CT-Scan / PET: brain, chest, abdomen,

pelvis– Serum lactate dehydrogenase

Page 5: STATEMENTS 2008 on Head and Neck Cancer Stephane TEMAM, M.D. PhD. Department of Head and Neck Surgery Mucosal Melanoma

Sites

• Nose and paranasal sinuses• Oral cavity

– Hard palate and maxillary alveolus

• Other sites : rare

Page 6: STATEMENTS 2008 on Head and Neck Cancer Stephane TEMAM, M.D. PhD. Department of Head and Neck Surgery Mucosal Melanoma

Surgery

• Radical and wide surgical resection

• Controversies– How large (2cm margins) : anatomical and

functional limitations as SCC– Extensive In Situ melanosis– Systematic treatment of the neck or SNB for

staging for oral melanoma– Therapeutic neck dissection is questionable

Page 7: STATEMENTS 2008 on Head and Neck Cancer Stephane TEMAM, M.D. PhD. Department of Head and Neck Surgery Mucosal Melanoma

Survival

• Recent reports:– Local control rate : 29% to 52%– 5-year overall survival rate : 20% to

35%– Long term survival patients– DM 47% to 62%

• associated with Local relapse• Positive neck nodes #100%

Page 8: STATEMENTS 2008 on Head and Neck Cancer Stephane TEMAM, M.D. PhD. Department of Head and Neck Surgery Mucosal Melanoma

Radiotherapy

• In vitro: a high capacity for repair of sublethal DNA-damage radioresistance

• Hypofractionation (dose/fraction>4Gy) recommended on a large non-randomized study, but not confirmed on a small size PIII RTOG trial for cutaneous M

• Limitation : proximity to the optical structures and the central nervous system.

Page 9: STATEMENTS 2008 on Head and Neck Cancer Stephane TEMAM, M.D. PhD. Department of Head and Neck Surgery Mucosal Melanoma

Radiotherapy

• Improve local control after surgery

• Indicated for unresecable disease

• Unresolved questions– Elective nodal irradiation– Total dose and Fractionation– New modalities : volume, neutron,

proton– Use of chemotherapy and possibly

new target therapy in concomittent or adjuvant setting

Page 10: STATEMENTS 2008 on Head and Neck Cancer Stephane TEMAM, M.D. PhD. Department of Head and Neck Surgery Mucosal Melanoma

Systemic treatment

• Palliative setting

• But also as adjuvant treatment for advanced stages– Cutaneous melanoma protocols– But different biology: cGH-arrays distinct

sets of genetic alterations